| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Biological, clinical and population relevance of 95 loci for blood lipids.
|
Nature
|
2010
|
28.21
|
|
2
|
Common variants at 30 loci contribute to polygenic dyslipidemia.
|
Nat Genet
|
2008
|
20.66
|
|
3
|
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease.
|
Nat Genet
|
2011
|
13.25
|
|
4
|
Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants.
|
Nat Genet
|
2009
|
12.19
|
|
5
|
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study.
|
Lancet
|
2012
|
12.10
|
|
6
|
A TALEN genome-editing system for generating human stem cell-based disease models.
|
Cell Stem Cell
|
2012
|
4.49
|
|
7
|
Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs.
|
Cell Stem Cell
|
2013
|
4.05
|
|
8
|
Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals.
|
PLoS Genet
|
2012
|
3.21
|
|
9
|
Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma.
|
Nat Genet
|
2011
|
3.18
|
|
10
|
Design of the Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Study: A Genome-wide association meta-analysis involving more than 22 000 cases and 60 000 controls.
|
Circ Cardiovasc Genet
|
2010
|
3.15
|
|
11
|
Programming human pluripotent stem cells into white and brown adipocytes.
|
Nat Cell Biol
|
2012
|
2.26
|
|
12
|
Two ZBP1 KH domains facilitate beta-actin mRNA localization, granule formation, and cytoskeletal attachment.
|
J Cell Biol
|
2002
|
2.20
|
|
13
|
Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies.
|
J Am Coll Cardiol
|
2010
|
2.17
|
|
14
|
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci.
|
Am J Hum Genet
|
2012
|
1.96
|
|
15
|
Generation of multipotent lung and airway progenitors from mouse ESCs and patient-specific cystic fibrosis iPSCs.
|
Cell Stem Cell
|
2012
|
1.72
|
|
16
|
Hepatic sortilin regulates both apolipoprotein B secretion and LDL catabolism.
|
J Clin Invest
|
2012
|
1.71
|
|
17
|
Defining the spectrum of alleles that contribute to blood lipid concentrations in humans.
|
Curr Opin Lipidol
|
2008
|
1.59
|
|
18
|
A mouse model of the human Fragile X syndrome I304N mutation.
|
PLoS Genet
|
2009
|
1.36
|
|
19
|
Clinical efficacy and safety of statins in managing cardiovascular risk.
|
Vasc Health Risk Manag
|
2008
|
1.30
|
|
20
|
The clinical utility of high-sensitivity C-reactive protein in cardiovascular disease and the potential implication of JUPITER on current practice guidelines.
|
Clin Chem
|
2008
|
1.25
|
|
21
|
Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9.
|
J Clin Invest
|
2014
|
1.13
|
|
22
|
Identifying patients at high risk of a cardiovascular event in the near future: current status and future directions: report of a national heart, lung, and blood institute working group.
|
Circulation
|
2010
|
1.07
|
|
23
|
Protein-RNA and protein-protein recognition by dual KH1/2 domains of the neuronal splicing factor Nova-1.
|
Structure
|
2011
|
1.01
|
|
24
|
Effect of patient visualization of coronary calcium by electron beam computed tomography on changes in beneficial lifestyle behaviors.
|
Am J Cardiol
|
2008
|
1.01
|
|
25
|
Gene-centric meta-analysis of lipid traits in African, East Asian and Hispanic populations.
|
PLoS One
|
2012
|
0.99
|
|
26
|
Clinical and research applications of carotid intima-media thickness.
|
Am J Cardiol
|
2009
|
0.94
|
|
27
|
Basic concepts and potential applications of genetics and genomics for cardiovascular and stroke clinicians: a scientific statement from the American Heart Association.
|
Circ Cardiovasc Genet
|
2015
|
0.93
|
|
28
|
Treatment of an anterior communicating artery aneurysm through an anomalous anastomosis from the cavernous internal carotid artery.
|
J Neurosurg
|
2002
|
0.86
|
|
29
|
Genome-Edited Human Pluripotent Stem Cell-Derived Macrophages as a Model of Reverse Cholesterol Transport-Brief Report.
|
Arterioscler Thromb Vasc Biol
|
2015
|
0.83
|
|
30
|
Guided antithrombotic therapy: current status and future research direction: report on a National Heart, Lung and Blood Institute working group.
|
Circulation
|
2012
|
0.83
|
|
31
|
Future translational applications from the contemporary genomics era: a scientific statement from the American Heart Association.
|
Circulation
|
2015
|
0.81
|
|
32
|
Translating research into therapies.
|
Cell
|
2012
|
0.81
|
|
33
|
Enhancing Literacy in Cardiovascular Genetics: A Scientific Statement From the American Heart Association.
|
Circ Cardiovasc Genet
|
2016
|
0.80
|
|
34
|
Biomarkers for prediction of cardiovascular events.
|
N Engl J Med
|
2007
|
0.80
|
|
35
|
Functional evaluation of genetic variation in complex human traits.
|
Hum Mol Genet
|
2012
|
0.77
|
|
36
|
Mapping Novel Pathways in Cardiovascular Disease Using eQTL Data: The Past, Present, and Future of Gene Expression Analysis.
|
Front Genet
|
2013
|
0.76
|
|
37
|
The Expressed Genome in Cardiovascular Diseases and Stroke: Refinement, Diagnosis, and Prediction: A Scientific Statement From the American Heart Association.
|
Circ Cardiovasc Genet
|
2017
|
0.76
|
|
38
|
The Stroke Genetics Network: living up to its potential.
|
Stroke
|
2013
|
0.75
|
|
39
|
Top advances in functional genomics and translational biology for 2011.
|
Circ Cardiovasc Genet
|
2012
|
0.75
|
|
40
|
Top advances in functional genomics and translational biology for 2012.
|
Circ Cardiovasc Genet
|
2013
|
0.75
|
|
41
|
The implications of the ezetimibe and simvastatin in hypercholesterolemia enhances atherosclerosis regression trial: a return to first principles.
|
Clin Cardiol
|
2008
|
0.75
|
|
42
|
Noncoding RNAs in Cardiovascular Disease: Current Knowledge, Tools and Technologies for Investigation, and Future Directions: A Scientific Statement From the American Heart Association.
|
Circ Genom Precis Med
|
2020
|
0.75
|
|
43
|
Reply: Loss-of-Function Mutations to Estimate Pharmacological ANGPTL3 Inhibition.
|
J Am Coll Cardiol
|
2017
|
0.75
|